Photo - Xfinito Biodesigns Private Limited
play_arrow
View
52008

Xfinito Biodesigns Private Limited

A deep tech startup developing Intelligent Medtech systems

India, Karnataka
Market: Internet and IT, Medicine, Electronics, Artificial Intelligence, Mobile applications
Stage of the project: Prototype or product is ready

Date of last change: 09.02.2022
Go to the owner's profile
3
equalizer from 2000
help
Calculated and estimated occupancy of the project (more about ratings)
My rating
1
2
3
4
5
6
7
8
9
10
Average rating:
 

Idea

Xfinito is building Xeuron.ai, an Intelligent platform to decipher the brain. The initial focus of Xeuron is the management of neurodegenerative disorders & biohacking.

Current Status

The technology supporting neuromodulations and biohacking has been under development since 2012 and has undergone an informal validation with 300 patients. We have received govt grants of around $30K and pre-seed equity investment of about $100K

Market

Customer Segments:
- Patients Wellness – Diabetes & Parkinsons
- Wellness Centers
- Rehab Center
- Pharmaceutical research and patient engagement programs
- Sports Medicine

Markets:
Asia, North America and Europe (Later can be expanded to Australia, Africa and South America)

Problem or Opportunity

Brain related disorders are common and mainly attributed to atrophy due to ageing. The main issue affecting these patients is declining personal and professional Quality of Life. Globally 10 Million people have Parkinson’s, 8% of the global population, i.e., 633 Million suffer from one or the other type of Neuropathy, and around 55 Million people globally have Dementia. The overall socio-economic burden due to neurodegenerative diseases is over 1.5 trillion dollars per year.

Solution (product or service)

We are developing xeuron.ai, intending to decipher the brain and help millions affected by neurodegenerative, cognitive, learning and behavioural disorders; to prevent, monitor progression, support interventions, provide therapy; and improve their professional and personal quality of life. The platform uses data from biomarkers and digital markers through wearables to monitor the neuro-physical health of patients and provide AI backed actionable insights to improve their productivity and health

Competitors

Currently, the competitors offer either passive footwear or smart insoles measuring pressure or temperature or both. Some of the smart insoles also offer motion analysis. However, none provide holistic measure nor evaluate nerve degenerations.

Passive Diabetic shoes do complement our offering and are potential collaborators. Similarly, some branded footwear giants like Skechers provide comfortable footwear and could collaborate for active footwear development.

The key differentiation & competitive advantage is intelligence backed by objective sensing to provide users with a personalized experience. The footwear and smartwatch could potentially detect various nerve degeneration much earlier than the manifestation of symptoms.

Finally, Given the healthcare space that we will be operating in, most footwear and wellness companies would either look to partner with us or acquire us instead of developing the system in-house, which gives us a defensible moat and opportunity to collaborate instead of competing.

Advantages or differentiators

The key differentiation & competitive advantage is intelligence backed by objective sensing to provide users with a personalized experience. The footwear and smartwatch could potentially detect various nerve degeneration much earlier than the manifestation of symptoms.

Finance

Primary Costs:
- Salaries
- Multisite Clinical Validation
- Manufacturing & Regulatory Approval
- Infrastructure for Quality product development

Revenue:
- B2C & B2B2C – Footwear & Smart Watch
- Technology Licensing
- B2B – Asset sales to the large brands
- Analytic services to the hospital for better treatment control

Business model

B2B2C
Sales Channel:
- Crowdfunding
- Online D2C & Affiliate Platform
- Patient Support Groups
Primary Costs:
- Salaries
- High-Performance Computing
- Genomics and blood biomarker testing centre
- Multisite Clinical Validation
- Manufacturing & Regulatory Approval
Revenue:
- D2C & B2B2C –for patients
- Technology Licensing
- B2B – Asset sales to the large brands
- Analytic services
Revenue Segments:
- Diabetic Patients
- Parkinson’s Patients
- Corporate Engagement Programs
- Wellness Centers
- Sports
- Orthopedics

Money will be spent on

- Human Resources
- Basic Infrastructure for Certifications
- Product Development & Marketing

Offer for investor

We are expecting to dilute up to 10% of the startup in this round however, we are open to negotiation in case of strategic value from the investor.

Team or Management

Risks

With intensive customer interactions and in-depth technical feasibility study, we have mitigated most of the challenges and have developed a user-centric concept.

Incubation/Acceleration programs accomplishment

- Completed Acceleration program Launch and Zoom 3.0 from IIM Udaipur incubation Centre
-1 year at Atal Great Lakes Balachandra Incubator, Chennai
- Incubated and funded by Derbi Foundation

Won the competition and other awards

July 2020: Medtechnovation by IESA and Derbi Foundation
Sept 2020: Awarded Govt Grant through Nidhi Prayas Scheme DST
Feb 2021: Awarded Govt Grant through MSME Design Clinic Scheme by IISc
March 2021: Winner Flexible Electronics Challenge by IIT Kanput and Meity, India
Nov 2021: Finalist, Swadeshi Microprocessor challenge
Nov 2021: Winner AWS Campus Fund Grand Challenge 2021

Invention/Patent

Technology Patents to be filed shortly:
- Xeuron Technology
- Intelligent Computing & Processing
Utility Patents to be filed:
- The Novelty in Shoe and Placements
- Conductive Materials & Sensing Technology
The patents will help in additional revenue through non-exclusive technology licensing. We plan to innovate in materials shortly, giving us an edge for customized
footwear.
Trademark of xeuron.ai registered in India
Regulation - We initially intend to enter as Wellness Devices for the target patient pool and in 2 years acquire US FDA

Photos

Photo 1 - A deep tech startup developing Intelligent Medtech systems
Photo 2 - A deep tech startup developing Intelligent Medtech systems
Photo 3 - A deep tech startup developing Intelligent Medtech systems
Photo 4 - A deep tech startup developing Intelligent Medtech systems
Photo 5 - A deep tech startup developing Intelligent Medtech systems

Product Video

5,00
1
2
3
4
5
1 voice
Sign in/Sign up
arrow_back
EN
more_horiz
close
visibility1137
star0
Add to favorites
Delete from favorites
share
close
thumb_up0
Like
Unlike
Idea
Current Status
Market
Problem or Opportunity
Solution (product or service)
Competitors
Advantages or differentiators
Finance
Invested in previous rounds, $
Business model
Money will be spent on
Offer for investor
Team or Management
Mentors & Advisors
Lead investor
Risks
Incubation/Acceleration programs accomplishment
Won the competition and other awards
Invention/Patent
Photos
Product Video
Presentation